drugset / Trial / NCT00540137
The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the possibility of an association between changes in neurocognitive function, as measured by a computerised test battery, and the use of two different highly active antiretroviral therapy (HAART) regimens in treatment naïve HIV-1 infected subjects commencing antiretroviral therapy.
Timeline
- Start
- 2007-07
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atazanavir | Other / unclassified | 300 mg | — |
| Comparator | Nevirapine | Small molecule | 400 mg | — |
| Comparator | Ritonavir | Other / unclassified | 100 mg | — |